Tag:
biologics
Latest Headlines
Latest Headlines
Pharma hunkers down for ongoing gov't assault
Branded drugmakers in the U.S. aren't happy about the Obama administration's proposal to cut biologics exclusivity to seven years from the previously agreed upon 12 years. But European pharma
Enlight spins off Entrega for oral biologic drug delivery
In-PharmaTechnologist.com is reporting that Boston-based Enlight Biosciences has formed a new company, Entrega, which will focus on oral drug delivery techniques. The new company will use its
Merck gives up on developing Aranesp copycat
Merck's ( NYSE: MRK ) decision to end efforts to copy Amgen's blockbuster Aranesp anemia drug shows how the emerging field of developing generic versions of biotechnology therapies won't be easy to
100 new Roche jobs at Singapore plant
Another 100 jobs will be on offer in Singapore next year at a new $500 million biologics plant set up by Swiss drug giant Roche, which officially opened on Tuesday. Report
Biologics to top pharma sales by 2014
What will the pharma landscape look like after all those big, traditional drugs drop off the patent cliff? Here's a hint: Big Pharma might consider changing its name to Big Biotech. By 2014, the
